Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Sitagliptin add-on to Metformin in T2DM
NCT01034111Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Mar 2010; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01034111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01034111.